The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Hematology

• Publication date

  2018-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10245332.2017.1372248PMID 28876197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How I treat FLT3-mutated AML.

  2017cited by this paper
• Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD-Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-Transplantation.

  2016cited by this paper
• Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length

  2015cited by this paper
• Evolving treatment strategies in patients with high-risk acute myeloid leukemia

  2014cited by this paper
• The Biology and Targeting of FLT3 in Pediatric Leukemia

  2014cited by this paper
• Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3.

  2013cited by this paper
• Meta-analysis for the potential application of FLT3-TKD mutations as prognostic indicator in non-promyelocytic AML.

  2012cited by this paper
• Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.

  2011cited by this paper
• FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.

  2008cited by this paper
• Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.

  2008cited by this paper
• Clinical implications of FLT3 mutations in pediatric AML.

  2006cited by this paper
• Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis

  2005cited by this paper
• No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.

  2005cited by this paper
• Analysis of FLT3 internal tandem duplication and D835 mutations in Chinese acute leukemia patients.

  2005cited by this paper
• Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients

  2004cited by this paper
• Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.

  2003cited by this paper
• Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

  2002cited by this paper
• Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain

  2002cited by this paper
• The roles of FLT3 in hematopoiesis and leukemia.

  2002cited by this paper
• Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

  2001cited by this paper
• Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells

  2001cited by this paper
• Identification of novel FLT‐3 Asp835 mutations in adult acute myeloid leukaemia

  2001cited by this paper
• Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

  2001cited by this paper
• FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high‐risk group

  2000cited by this paper
• Essential Role of Signal Transducer and Activator of Transcription (Stat)5a but Not Stat5b for Flt3-Dependent Signaling

  2000cited by this paper
• Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia

  1997cited by this paper
• Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.

  1996cited by this paper
• Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

  1996cited by this paper
• Biology of flt3 ligand and receptor.

  1995cited by this paper
• Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells.

  1994cited by this paper
• Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs

  1994cited by this paper
• STK-1 receptor gene is expressed in various human non-hematopoietic tumor cell lines--RT-PCR directed analysis of STK-1 mRNA expression. Preliminary report.

  1994cited by this paper
• Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells.

  1993cited by this paper
• Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells.

  1993cited by this paper
• A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations.

  1991cited by this paper

• The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next‐generation sequencing in adult acute myeloid leukemia patients with the FLT3‐ITD mutation

  2023cites this paper
• The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next- generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutation

  2022cites this paper
• GSK3 inhibitor suppresses cell growth and metabolic process in FLT3-ITD leukemia cells

  2022cites this paper
• A novel prognostic scoring model for newly diagnosed FLT3-ITD-positive acute myeloid leukemia.

  2020cites this paper
• Laboratory Assays in Patients with Acute Promyelocytic Leukemia and FLT3-TKD Mutations

  2020cites this paper
• Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era

  2020cites this paper
• The Role of FLT3‐ITD Mutation on de Novo MDS in Chinese Population

  2019cites this paper
• FLT3 Receptor Heterogeneity Strictly Specifies theDimensions of Malignant Transformation Events in AcuteMyeloid Leukemia

  2017cites this paper